Paper Details 
Original Abstract of the Article :
During recent years, the treatment of pulmonary diseases could be significantly improved due to the introduction of modern retrometabolism-based corticosteroids with improved therapeutic ratio. It is the goal of all inhaled corticosteroids to produce long lasting therapeutic effects at the pulmonary...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/10756545

データ提供:米国国立医学図書館(NLM)

Optimizing Inhaled Corticosteroids: Retrometabolism for Improved Therapeutic Ratio

Inhaled corticosteroids are a mainstay of treatment for pulmonary diseases like asthma and chronic obstructive pulmonary disease (COPD). These medications aim to reduce inflammation in the lungs while minimizing systemic side effects. This study explores the concept of retrometabolism, a process that can enhance the therapeutic ratio of inhaled corticosteroids by optimizing their pharmacokinetic and pharmacodynamic properties.

Retrometabolism: A New Approach to Drug Design

The authors developed a pharmacokinetic/pharmacodynamic (PK/PD) model to predict the effects of different inhaled corticosteroids based on dose. They compared the model’s predictions to clinical trial data for four different corticosteroids, finding a strong correlation. This suggests that retrometabolism can be used to optimize the design of inhaled corticosteroids, leading to improved therapeutic outcomes.

Potential for Improved Treatment of Pulmonary Diseases

This research highlights the potential of retrometabolism for enhancing the therapeutic ratio of inhaled corticosteroids. By optimizing their PK/PD properties, retrometabolism could lead to more effective and safer treatment for pulmonary diseases. Further research is needed to validate these findings and explore the full potential of retrometabolism for improving inhaled corticosteroid therapy.

Dr.Camel's Conclusion

Think of inhaled corticosteroids as a desert oasis providing life-sustaining water for camels suffering from lung ailments. Retrometabolism acts like a skilled oasis manager, optimizing the water flow and ensuring a balanced supply for all. This research highlights the potential of retrometabolism to improve the effectiveness and safety of inhaled corticosteroids, ensuring a healthy oasis for camels in need. It’s like finding a perfectly managed oasis, providing the right amount of water at the right time for optimal well-being.

Date :
  1. Date Completed 2000-05-03
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

10756545

DOI: Digital Object Identifier

10756545

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.